Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors (Q34938807)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors |
scientific article |
Statements
1 reference
Prevalence of neutralizing antibodies against adeno-associated virus (AAV) types 2, 5, and 6 in cystic fibrosis and normal populations: Implications for gene therapy using AAV vectors (English)
1 reference
A Dusty Miller
1 reference
Christine L Halbert
1 reference
Sharon McNamara
1 reference
Julia Emerson
1 reference
Ronald L Gibson
1 reference
Bonnie Ramsey
1 reference
Moira L Aitken
1 reference
1 April 2006
1 reference
1 reference
17
1 reference
4
1 reference
440-447
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference